18 Amendments of Jan HUITEMA related to 2017/2254(INI)
Amendment 17 #
Motion for a resolution
Recital A
Recital A
A. whereas the excessive and inappropriatecorrect use of antibiotics and poor infection control practices in both human and veterinary medicine have progressively rendered antimicrobial resistance (AMR) a massive threat to humankind;
Amendment 20 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on the Commission and the Member States to take an ambitious and leading approach to ensuring that the targets set out in their respective Action Plans are fully and effectively achieved, and to strictly monitor the results that have been achieved;
Amendment 35 #
Motion for a resolution
Recital B
Recital B
B. whereas the misincorrect use of antibiotics is eroding their efficacy and leading to the spread of highly resistant bacteria that are especially resistant to last- line antibiotics; whereas according to data provided by the OECD, an estimated 700 000 deaths worldwide may be caused by AMR every year;
Amendment 37 #
Draft opinion
Paragraph 3
Paragraph 3
3. Calls for legislative solutions that will assist farmers in reducing the use of antibiotics in livestock farming, with the aim of prudent and responsible use of antimicrobials; insists that such legislative solutions must address prophylactic and metaphylactic use; endeavours to keep the additional administrative burden as small as possible;
Amendment 58 #
Draft opinion
Paragraph 4
Paragraph 4
4. Calls for further research and development into new antimicrobials and encourages alternatives, such as vaccines, to be investigated, including the development of more sustainable farming systems based on less intensive farming modelsand animal friendly farming models to ensure adequate animal husbandry;
Amendment 68 #
Motion for a resolution
Recital E b (new)
Recital E b (new)
Eb. whereas action to reduce veterinary antimicrobial use has been uneven across EU countries as the latest data from the European Medicine Agency shows1a; whereas some Member States have achieved significant reductions in the use of veterinary antimicrobials over a short period of time thanks to ambitious national policies, as illustrated by a series of fact-finding missions carried out by the European Commission Health and Food Audits and Analysis Directorate1aa; _________________ 1a http://www.ema.europa.eu/ema/index.jsp? curl=pages/news_and_events/news/2017/1 0/news_detail_002827.jsp∣ =WC0b01ac05 8004d5c1antimicrobials 1aa http://ec.europa.eu/food/audits- analysis/audit_reports/index.cfm
Amendment 75 #
Motion for a resolution
Recital E c (new)
Recital E c (new)
Amendment 79 #
Draft opinion
Paragraph 5
Paragraph 5
5. Stresses that disease prevention must be the first step for legislation tackling AMR in agriculture, both to ensure a high standard of animal welfare and reduce the need to resort to antibiotics; believedemands that antibiotics should never be used as compensation for poor hygiene or inadequate animal husbandry;
Amendment 87 #
Draft opinion
Paragraph 6
Paragraph 6
6. Calls on the Commission and the Member States to ensure adequate funding for6. Believes that on-farm investments, such as in quality housing, ventilation, cleaning, disinfection, vaccination and bio-security, probiotics, prebiotics, gen- selection and bio-security must be encouraged and should not be undermined in the future CAP;
Amendment 98 #
Draft opinion
Paragraph 7
Paragraph 7
7. Emphasises the crucial role of education and training programmes, based on the latest scientific developments, in raising awareness about antimicrobial resistance and the prudent use of antimicrobials in veterinary medicine for farmers and those involved in livestock farming;
Amendment 102 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that the appropriatecorrect and prudent use of antimicrobials is essential to limiting the emergence of AMR in human healthcare, animal husbandry and aquaculture; stresses that there are considerable differences in the way Member States handle and address AMR; calls on the Commission to consider mandatory routine collection and submission of monitoring data at EU level and to establish indictors to measure progress in the fight against AMR;
Amendment 118 #
Draft opinion
Paragraph 8
Paragraph 8
8. Underlines the need to change the business culture employed by veterinary medicine producers, which encourages the use and overuse of certain medicines in order to generate profitslosely cooperate with veterinary medicine producers in order to diminish the use of certain medicines with high AMR-Impact; emphasizes that public-private partnerships are essential for the One- Health approach;
Amendment 135 #
Draft opinion
Paragraph 9
Paragraph 9
9. Notes that the use of antibiotics as growth promoters in food-producing animals has been banned in the EU since 2006; calls on the Commission to enforce this ban as a conditionality to all food imports from third countries through Free Trade Agreements;
Amendment 225 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls on the Commission and the Member States to restrict or stop the sale of antibiotics by those, in line with the 1999 SSC report, eliminate inducements, especially financial, for doctors orand veterinarians whoen prescribe theming antibiotics;
Amendment 246 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11 a. Calls on the Commission to take firm action against the illegal sale of antimicrobial products in the EU;
Amendment 258 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Highlights the value of vaccines, probiotics and prebiotics in combating AMR; recommends integration of targets for life-long vaccination as a key element of national action plans on AMR;
Amendment 320 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15 a. Urges the European Commission to consider a new legislative framework to stimulate the development of new antimicrobials for humans, as already requested by the European Parliament on 10 March 2016 on the proposal for a regulation of the European Parliament and of the Council on veterinary medicinal products and in the parliamentary resolution (2015) 0197 of19 May 2015; notes that the Commission “One Health” Action Plan against AMR also commits itself to “analyse EU regulatory tools and incentives - in particular orphan and paediatric legislation – to use them for novel antimicrobials".
Amendment 390 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Calls on the Commission and Member States to work together with the industry to develop new incentive models that delink payment from prescribing volume;